254 related articles for article (PubMed ID: 28482875)
1. Qualitative insights into how men with low-risk prostate cancer choosing active surveillance negotiate stress and uncertainty.
Mader EM; Li HH; Lyons KD; Morley CP; Formica MK; Perrapato SD; Irwin BH; Seigne JD; Hyams ES; Mosher T; Hegel MT; Stewart TM
BMC Urol; 2017 May; 17(1):35. PubMed ID: 28482875
[TBL] [Abstract][Full Text] [Related]
2. Perception of cancer and inconsistency in medical information are associated with decisional conflict: a pilot study of men with prostate cancer who undergo active surveillance.
Goh AC; Kowalkowski MA; Bailey DE; Kazer MW; Knight SJ; Latini DM
BJU Int; 2012 Jul; 110(2 Pt 2):E50-6. PubMed ID: 22145791
[TBL] [Abstract][Full Text] [Related]
3. Psychosocial barriers to active surveillance for the management of early prostate cancer and a strategy for increased acceptance.
Pickles T; Ruether JD; Weir L; Carlson L; Jakulj F;
BJU Int; 2007 Sep; 100(3):544-51. PubMed ID: 17532857
[TBL] [Abstract][Full Text] [Related]
4. 'What is this active surveillance thing?' Men's and partners' reactions to treatment decision making for prostate cancer when active surveillance is the recommended treatment option.
O'Callaghan C; Dryden T; Hyatt A; Brooker J; Burney S; Wootten AC; White A; Frydenberg M; Murphy D; Williams S; Schofield P
Psychooncology; 2014 Dec; 23(12):1391-8. PubMed ID: 24830805
[TBL] [Abstract][Full Text] [Related]
5. Psychosocial aspects of active surveillance.
Kazer MW; Psutka SP; Latini DM; Bailey DE
Curr Opin Urol; 2013 May; 23(3):273-7. PubMed ID: 23422588
[TBL] [Abstract][Full Text] [Related]
6. Active surveillance for low-risk localized prostate cancer: what do men and their partners think?
Mallapareddi A; Ruterbusch J; Reamer E; Eggly S; Xu J
Fam Pract; 2017 Feb; 34(1):90-97. PubMed ID: 28034917
[TBL] [Abstract][Full Text] [Related]
7. The self-management of uncertainty among men undertaking active surveillance for low-risk prostate cancer.
Oliffe JL; Davison BJ; Pickles T; Mróz L
Qual Health Res; 2009 Apr; 19(4):432-43. PubMed ID: 19229061
[TBL] [Abstract][Full Text] [Related]
8. Uncertainty and quality of life among men undergoing active surveillance for prostate cancer in the United States and Ireland.
Hegarty JM; Wallace M; Comber H
Am J Mens Health; 2008 Jun; 2(2):133-42. PubMed ID: 19477777
[TBL] [Abstract][Full Text] [Related]
9. Factors influencing men undertaking active surveillance for the management of low-risk prostate cancer.
Davison BJ; Oliffe JL; Pickles T; Mroz L
Oncol Nurs Forum; 2009 Jan; 36(1):89-96. PubMed ID: 19136342
[TBL] [Abstract][Full Text] [Related]
10. Predictors of health-related quality of life and adjustment to prostate cancer during active surveillance.
Bellardita L; Rancati T; Alvisi MF; Villani D; Magnani T; Marenghi C; Nicolai N; Procopio G; Villa S; Salvioni R; Valdagni R
Eur Urol; 2013 Jul; 64(1):30-6. PubMed ID: 23357351
[TBL] [Abstract][Full Text] [Related]
11. Active surveillance in prostate cancer: a concept analysis.
Horrill T
J Clin Nurs; 2016 Apr; 25(7-8):1166-72. PubMed ID: 26786713
[TBL] [Abstract][Full Text] [Related]
12. Decision-making processes among men with low-risk prostate cancer: A survey study.
Hoffman RM; Van Den Eeden SK; Davis KM; Lobo T; Luta G; Shan J; Aaronson D; Penson DF; Leimpeter AD; Taylor KL
Psychooncology; 2018 Jan; 27(1):325-332. PubMed ID: 28612468
[TBL] [Abstract][Full Text] [Related]
13. Decision-Making in Prostate Cancer – Choosing Active Surveillance Over Other Treatment Options: A Literature Review.
Bayliss DR; Duff J; Stricker P; Walker K
Urol Nurs; 2017; 37(1):15-22. PubMed ID: 29240360
[TBL] [Abstract][Full Text] [Related]
14. Watching, waiting and uncertainty in prostate cancer.
Bailey DE; Wallace M; Mishel MH
J Clin Nurs; 2007 Apr; 16(4):734-41. PubMed ID: 17402955
[TBL] [Abstract][Full Text] [Related]
15. The Relationship between Intolerance of Uncertainty and Anxiety in Men on Active Surveillance for Prostate Cancer.
Tan HJ; Marks LS; Hoyt MA; Kwan L; Filson CP; Macairan M; Lieu P; Litwin MS; Stanton AL
J Urol; 2016 Jun; 195(6):1724-30. PubMed ID: 26872841
[TBL] [Abstract][Full Text] [Related]
16. Population based study of use and determinants of active surveillance and watchful waiting for low and intermediate risk prostate cancer.
Loeb S; Berglund A; Stattin P
J Urol; 2013 Nov; 190(5):1742-9. PubMed ID: 23727309
[TBL] [Abstract][Full Text] [Related]
17. Patient perspective on watchful waiting/active surveillance for localized prostate cancer.
Xu J; Neale AV; Dailey RK; Eggly S; Schwartz KL
J Am Board Fam Med; 2012; 25(6):763-70. PubMed ID: 23136314
[TBL] [Abstract][Full Text] [Related]
18. Treatment Preferences for Active Surveillance versus Active Treatment among Men with Low-Risk Prostate Cancer.
Taylor KL; Hoffman RM; Davis KM; Luta G; Leimpeter A; Lobo T; Kelly SP; Shan J; Aaronson D; Tomko CA; Starosta AJ; Hagerman CJ; Van Den Eeden SK
Cancer Epidemiol Biomarkers Prev; 2016 Aug; 25(8):1240-50. PubMed ID: 27257092
[TBL] [Abstract][Full Text] [Related]
19. Patient acceptance of active surveillance as a treatment option for low-risk prostate cancer.
Davison BJ; Goldenberg SL
BJU Int; 2011 Dec; 108(11):1787-93. PubMed ID: 21507187
[TBL] [Abstract][Full Text] [Related]
20. Strategies adopted by men to deal with uncertainty and anxiety when following an active surveillance/monitoring protocol for localised prostate cancer and implications for care: a longitudinal qualitative study embedded within the ProtecT trial.
Wade J; Donovan J; Lane A; Davis M; Walsh E; Neal D; Turner E; Martin R; Metcalfe C; Peters T; Hamdy F; Kockelbergh R; Catto J; Paul A; Holding P; Rosario D; Kynaston H; Rowe E; Hughes O; Bollina P; Gillatt D; Doherty A; Gnanapragasam VJ; Paez E
BMJ Open; 2020 Sep; 10(9):e036024. PubMed ID: 32907896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
